GEC | Jotup

NCLA Defeats Motion to Dismiss, Wins Expedited Discovery in Suit Alleging State Dept. Censorship

Retrieved on:

수요일, 5월 8, 2024

NCLA, GEC, Democracy, News, State, The Daily Wire, Freedom, Speech, NewsGuard, Federalist, District court, Court, Marketing, Advertising, First, Organization, Constitutional right

NCLA looks forward to revealing the true depth of this egregious censorship regime via expedited discovery, and to stopping the State Department from abridging Americans’ civil liberties.

Key Points:

NCLA looks forward to revealing the true depth of this egregious censorship regime via expedited discovery, and to stopping the State Department from abridging Americans’ civil liberties.
The State Department’s censorship regime violates the First Amendment rights of The Daily Wire, The Federalist, numerous similar outlets, and their readers.
Expedited discovery will enable our clients to win a preliminary injunction enjoining Defendants’ unconstitutional and ultra vires conduct.
The expedited discovery ordered today will allow NCLA to bring to light the government’s unconstitutional conduct—and put a halt to it.”

Debbie's Dream Foundation: Curing Stomach Cancer Supports Pioneering Gastroesophageal Cancer Research Retreat

Retrieved on:

수요일, 5월 8, 2024

Education, Organization, GEC, Partnership, Research, Stomach cancer, DRS, MSK, Patient advocacy, Samuel, Health, EST, Quality of life, DDF, Pharmaceutical industry

NEW YORK, May 8, 2024 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is proud to announce its collaboration with Memorial Sloan Kettering Cancer Center (MSK) at the upcoming Gastroesophageal Cancer Research Center Retreat. This invitation-only event will occur on Friday, May 10, 2024, from 8:00 a.m. to 6:00 p.m. EST and will feature impactful discussions among leading Gastroesophageal Cancer (GEC) researchers. The program will be led by esteemed figures such as Drs. Yelena Janjigian, Smita Joshi, and Samuel Cytryn, who are at the forefront of GEC research and patient care at MSK. DDF will participate in the retreat's Patient Advocacy and Case Discussion, which will take place at 5:00 p.m. EST, as a key supporter and a pioneering patient advocacy group.

Key Points:

NEW YORK, May 8, 2024 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is proud to announce its collaboration with Memorial Sloan Kettering Cancer Center (MSK) at the upcoming Gastroesophageal Cancer Research Center Retreat.
Yelena Janjigian, Smita Joshi, and Samuel Cytryn, who are at the forefront of GEC research and patient care at MSK.
This incredible collaboration builds on DDF and MSK's partnership for the "Debbie's Dream Early Career Investigator in Gastroesophageal Cancer" fellowship announced earlier this year.
The three-year fellowship will be executed under the leadership of Dr. Yelena Janjigian at MSK, emphasizing both organizations' commitment to pioneering cancer research and education.

VEON management increases share ownership

Retrieved on:

금요일, 4월 12, 2024

STI, LTI, VEON, TSR, Tax, GEC, Incentive

In connection with these above mentioned share awards, VEON’s Group Executive Committee (“GEC”) received a total of 2,299,995 VEON common shares (equal to 91,999 VEON American Depositary Shares (“ADSs”)) within the scope of the VEON’s Deferred Share plans, and the GEC were granted a total of 10,457,359 VEON common shares (equal to 418,294 ADSs) as a part of the LTI plans.

Key Points:

In connection with these above mentioned share awards, VEON’s Group Executive Committee (“GEC”) received a total of 2,299,995 VEON common shares (equal to 91,999 VEON American Depositary Shares (“ADSs”)) within the scope of the VEON’s Deferred Share plans, and the GEC were granted a total of 10,457,359 VEON common shares (equal to 418,294 ADSs) as a part of the LTI plans.
As previously announced, GEC members are required to accrue and maintain a minimum level of VEON shares.
1 The STI 2023 share awards were granted as part of VEON’s Deferred Share Plan.
The Deferred Share grant, which represents 50% of the Short-Term Incentives (“STI”) scheme, relates to the period from 1 January 2023 to 31 December 2023 and is deferred into shares under the Deferred Share grant rules.

Lakeview Issues Open Letter to Pitney Bowes’ Board of Directors Calling for Expeditious Sale of GEC

Retrieved on:

화요일, 4월 30, 2024

Professional Services, Finance, Churn, Pitney Bowes, Sale, Pitney, CFO, GEC, Burn, Chairperson, Annual general meeting

Lakeview Investment Group & Trading Company, LLC, which beneficially owns approximately 2.55% of the outstanding common shares of Pitney Bowes, Inc. (NYSE: PBI) (“Pitney Bowes” or the “Company”), today issued the below open letter to the Company’s Board of Directors.

Key Points:

Lakeview Investment Group & Trading Company, LLC, which beneficially owns approximately 2.55% of the outstanding common shares of Pitney Bowes, Inc. (NYSE: PBI) (“Pitney Bowes” or the “Company”), today issued the below open letter to the Company’s Board of Directors.
Lakeview has a record of engaging with boards of directors and management teams to help them improve governance and initiate value-enhancing actions.
By continuing its pursuit of unprofitable volume and nonexistent scale within GEC, Pitney Bowes continues to burn cash.
Longer term, we believe the Board should evaluate all strategic alternatives to maximize shareholder value, including a sale of the entire Company.

SASOL ANNOUNCES STREAMLINED GROUP EXECUTIVE COMMITTEE, INCLUDING CHANGES TO IMPORTANT FUNCTIONS AND EXECUTIVE RESPONSIBILITIES OF DIRECTORS

Retrieved on:

수요일, 4월 3, 2024

Information management, GEC, Corporate Affairs, Sasol, Marketing, Intellectual property, Management

JOHANNESBURG, April 3, 2024 /PRNewswire/ -- Sasol has streamlined the portfolios of the members of its Group Executive Committee (GEC).

Key Points:

JOHANNESBURG, April 3, 2024 /PRNewswire/ -- Sasol has streamlined the portfolios of the members of its Group Executive Committee (GEC).
Effective 1 April 2024, Sasol's GEC comprises the following members:
Mr Simon Baloyi, Executive Director and President and Chief Executive Officer;
Mr Hanré Rossouw, Executive Director and Group Chief Financial Officer;
Mr Vuyo Kahla, Executive Director and Executive Vice President: Commercial and Legal, responsible for Legal, Intellectual Property and Compliance, Assurance, Information Management, Supply Chain and Company Secretarial Services;
Mr Victor Bester, Executive Vice President: Operations and Projects Southern Africa;
Mr Christian Herrmann, Executive Vice President: Marketing and Sales Energy and Chemicals Southern Africa;
Ms Charlotte Mokoena, Executive Vice President: Human Resources and Corporate Affairs;
Mr Brad Griffith, Executive Vice President: Chemicals Business.
Mr Griffith will retire on 30 June 2024 and will be succeeded by Ms Antje Gerber on 15 April 2024, who joins Sasol as Executive Vice President: International Chemicals.

PMB Aerospace Corporation Announces Exclusive License of Battery Technology

Retrieved on:

월요일, 3월 11, 2024

EV, PMB, GEC, NASA, OTC, Transport, Generating, Permanent magnet motor, Research, Sustainable energy

LOS ANGELES, March 11, 2024 (GLOBE NEWSWIRE) -- PMB AEROSPACE CORPORATION (OTC: PMBY) (“the Company”), announces it has become the exclusive license holder of Global Energy Corporation’s (GEC) ‘Trickle Charger’ technology.

Key Points:

LOS ANGELES, March 11, 2024 (GLOBE NEWSWIRE) -- PMB AEROSPACE CORPORATION (OTC: PMBY) (“the Company”), announces it has become the exclusive license holder of Global Energy Corporation’s (GEC) ‘Trickle Charger’ technology.
PMB Aerospace intends to produce a new advanced electric battery drive system which does not need overnight or street charging with a range of 100,000 miles.
For existing EV’s, the ‘Trickle Charger’ will be attached to current EV batteries, giving consumers the direct benefit of the technology.
The target market will be the entire battery, transportation, and generator markets, along with the electric vehicle market.

NCLA Seeks Injunction to Halt U.S. State Department-Funded Censorship of Domestic Speech & Press

Retrieved on:

수요일, 2월 7, 2024

NCLA proudly represents these outlets in The Daily Wire, The Federalist, State of Texas v. State Dept.

Key Points:

NCLA proudly represents these outlets in The Daily Wire, The Federalist, State of Texas v. State Dept.
and now urges the Court to block this blatantly unlawful censorship regime before it can further abridge Americans’ civil liberties.
The State Department’s censorship regime violates the First Amendment rights of The Daily Wire, The Federalist, numerous similar outlets, and their readers.
A preliminary injunction would prevent the State Department’s unconstitutional acts from further irreparably harming The Daily Wire, The Federalist, and the State of Texas.

NCLA Launches Lawsuit Against U.S. State Department-Funded Censorship Regime

Retrieved on:

수요일, 12월 6, 2023

The State Department uses its Global Engagement Center (“GEC”) to finance the development and promotion of censorship technology and enterprises, including NewsGuard and the Global Disinformation Index.

Key Points:

The State Department uses its Global Engagement Center (“GEC”) to finance the development and promotion of censorship technology and enterprises, including NewsGuard and the Global Disinformation Index.
The State Department’s censorship scheme clearly violates the First Amendment rights of The Daily Wire, The Federalist, and numerous similar outlets.
NCLA is proud to represent The Daily Wire and The Federalist again, having won important victories with them in the past.
NCLA will fight the State Department’s censorship scheme alongside these news outlets for as long as it takes.

Lexmark Products Dominate EPEAT Climate+ Champion Status in Imaging Equipment Category

Retrieved on:

화요일, 10월 24, 2023

Internet of things, Carbon, Organization, Environment, GEC, GHG, Electronics, Imaging, EPEAT, Climate change, Renewable energy, Lexmark

LEXINGTON, Ky., Oct. 24, 2023 /PRNewswire/ -- Lexmark, a global imaging and IoT solutions leader, today announced that 42 of its imaging products are among the first to earn the stringent new EPEAT® Climate+™ designation from the Global Electronics Council™ (GEC). A total of 43 products earned the EPEAT Climate+ distinction in the Imaging Equipment product category when the program launched on Oct. 3, 2023, 42 of which are from Lexmark.

Key Points:

LEXINGTON, Ky., Oct. 24, 2023 /PRNewswire/ -- Lexmark, a global imaging and IoT solutions leader, today announced that 42 of its imaging products are among the first to earn the stringent new EPEAT® Climate+™ designation from the Global Electronics Council ™ (GEC).
A total of 43 products earned the EPEAT Climate+ distinction in the Imaging Equipment product category when the program launched on Oct. 3, 2023, 42 of which are from Lexmark.
The products set themselves apart on the EPEAT Registry because of these climate change mitigation measures.
"We are proud that Lexmark products account for 42 of the 43 imaging products that meet the stringent EPEAT Climate+ requirements," said John Gagel, Chief Sustainability Officer, Lexmark.

Mission Bio Announces High Precision Detection of Variants For Tapestri® Platform in NIST Genome Editing Consortium Initial Study

Retrieved on:

월요일, 10월 23, 2023

Mission Bio , a leader in single-cell multi-omic solutions for precision medicine, announced today initial results from the National Institute of Standards and Technology (NIST) Genome Editing Consortium's inaugural Interlab Study.

Key Points:

Mission Bio , a leader in single-cell multi-omic solutions for precision medicine, announced today initial results from the National Institute of Standards and Technology (NIST) Genome Editing Consortium's inaugural Interlab Study.
The NIST Genome Editing Consortium (GEC) was created to meet the growing demand for enhancing the confidence in genome editing technologies by supporting quality and standardization in analysis.
In 2018, Mission Bio joined the consortium to provide single-cell resolution of genome editing outcomes.
The one-day public workshop hosted by NIST will discuss current and future efforts of the NIST Genome Editing Consortium.